Ring AM, Lin JX, Feng D, Mitra S, Rickert M, Bowman GR, Pande VS, Li P, Moraga I, Spolski R, Ozkan E, Leonard WJ, Garcia KC.
Natural Immunology (Dec 2012)
SUMMARY.
This is a continuation of paper #100, āExploiting a natural conformational switch to engineer an interleukin-2 āsuperkineāā. Our results provide new insights for the development of new specific therapeutics based on interleukin.
ABSTRACT.
Interleukin 15 (IL-15) and IL-2 have distinct immunological functions even though both signal through the receptor subunit IL-2RĪ² and the common Ī³-chain (Ī³(c)). Here we found that in the structure of the IL-15-IL-15RĪ±-IL-2RĪ²-Ī³(c) quaternary complex, IL-15 binds to IL-2RĪ² and Ī³(c) in a heterodimer nearly indistinguishable from that of the IL-2-IL-2RĪ±-IL-2RĪ²-Ī³(c) complex, despite their different receptor-binding chemistries. IL-15RĪ± substantially increased the affinity of IL-15 for IL-2RĪ², and this allostery was required for IL-15 trans signaling. Consistent with their identical IL-2RĪ²-Ī³(c) dimer geometries, IL-2 and IL-15 showed similar signaling properties in lymphocytes, with any differences resulting from disparate receptor affinities. Thus, IL-15 and IL-2 induced similar signals, and the cytokine specificity of IL-2RĪ± versus IL-15RĪ± determined cellular responsiveness. Our results provide new insights for the development of specific immunotherapeutics based on IL-15 or IL-2.